Tag : Transgene

Latest News

Riassunto: Transgene e NEC avviano due sperimentazioni cliniche su TG4050, un vaccino anticancro basato su IA diretto contro i tumori dell’ovaio, della testa e del collo

Newsemia
STRASBURGO, Francia e TOKYO–(BUSINESS WIRE)–Transgene (Euronext Parigi: TNG), una società biotecnologica impegnata nella progettazione e nello sviluppo di immunoterapie oncologiche basate su virus, e NEC...
Latest News

Transgene Provides an Update after the Interim Futility Analysis of the PHOCUS Study of Pexa-Vec in Liver Cancer

Newsemia
STRASBOURG, France–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/Transgene?src=hash" target="_blank">#Transgene</a>–Regulatory News: Transgene (Paris:TNG), a biotech company designing and developing virus-based immunotherapies for the treatment of solid tumors, provides an update...
Latest News

Transgene annonce l’inclusion du dernier patient de l’essai de Phase 2 avec TG4010 + Nivolumab + Chimiothérapie en 1ère ligne de traitement du cancer du poumon au stade avancé

Newsemia
STRASBOURG, France–(BUSINESS WIRE)–Regulatory News: Transgene (Paris:TNG), société de biotechnologie qui conçoit et développe des immunothérapies reposant sur des vecteurs viraux contre les cancers et les...
Latest News

Experimental gene therapy extends lifespan of mice suffering from untreatable mitochondrial disease

Newsemia
Researchers at the University of Helsinki and Folkhälsan Research Center have, together with their collaborators, for the first time demonstrated in a mouse model that...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy